EUVIMEDEUVIMED entdecken
Crossref

Developments in clinical practice treating systemic lupus erythematosus—A single-centre retrospective longitudinal study in Japan

Kentaro Minowa iD, Yusuke Yanagimoto, Eitaro Yoshida, Ayako Makiyama iD, Makio Kusaoi iD, Masakazu Matsushita iD, Hirofumi Amano, Ken Yamaji iD, Naoto Tamura iD

Modern Rheumatology · 2026

DOI: 10.1093/mr/roag001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2026. Verfasst von Kentaro Minowa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Glucocorticoids, Hydroxychloroquine, Immunosuppressive Agents. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess treatment patterns for systemic lupus erythematosus from 2012 to 2024 and evaluate corresponding changes in serological activity and relapse rates.

Methods

We retrospectively reviewed medical records of 1705 patients with systemic lupus erythematosus treated at a single centre between 2012 and 2024. Temporal trends in therapeutic approaches, glucocorticoid (GC) use, and clinical outcomes were analysed.

Results

Use of GC monotherapy declined from 58.3% in 2012 to 22.4% in 2024. Combination therapies (GC and hydroxychloroquine, with or without immunosuppressants) increased from 1.0% in 2015 to 41.6% in 2024, while biologics use rose from 0.9% in 2018 to 12.5% in 2024. Quadruple therapy (GC, hydroxychloroquine, immunosuppressants, and biologics) also expanded from 0.4% in 2018 to 6.2% in 2024. The mean GC dose decreased from 7.7 mg/day in 2012 to 4.6 mg/day in 2024, and the median dose, stable at 5 mg/day for many years, declined to 4.6 mg in 2023 and 4.2 mg in 2024. The proportion of patients with elevated serological activity steadily decreased. Flare rates peaked at 8.1% in 2016 but stabilised at ~4% after 2020.

Conclusions

These findings suggest that improved disease control can increasingly be achieved in real-world practice while reducing long-term GC dependence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicGlucocorticoidsHydroxychloroquineImmunosuppressive AgentsBiological ProductsHumansRetrospective StudiesJapanFemaleLongitudinal StudiesDrug Therapy, CombinationMaleAdultMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

BiologicsJapandisease controlglucocorticoidshydroxychloroquinereal-world datarelapseserological activitysystemic lupus erythematosustreatment patterns

Substanzen

GlucocorticoidsHydroxychloroquineImmunosuppressive AgentsBiological Products

Autor:innen und Institutionen

  • Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
  • Department of Internal Medicine and Rheumatology, Juntendo University Nerima Hospital, Tokyo, Japan.

ORCID-Profile: Kentaro Minowa, Ayako Makiyama, Makio Kusaoi, Masakazu Matsushita, Ken Yamaji, Naoto Tamura

Zitieren

APA

Minowa, K., Yanagimoto, Y., Yoshida, E., Makiyama, A., Kusaoi, M., Matsushita, M., Amano, H., Yamaji, K., & Tamura, N. (2026). Developments in clinical practice treating systemic lupus erythematosus—A single-centre retrospective longitudinal study in Japan. Modern Rheumatology. https://doi.org/10.1093/mr/roag001

Vancouver

Minowa K, Yanagimoto Y, Yoshida E, Makiyama A, Kusaoi M, Matsushita M, et al. Developments in clinical practice treating systemic lupus erythematosus—A single-centre retrospective longitudinal study in Japan. Modern Rheumatology. 2026. doi:10.1093/mr/roag001

BibTeX
@article{Minowa2026,
  author = {Minowa, Kentaro and Yanagimoto, Yusuke and Yoshida, Eitaro and Makiyama, Ayako and Kusaoi, Makio and Matsushita, Masakazu and Amano, Hirofumi and Yamaji, Ken and Tamura, Naoto},
  title = {Developments in clinical practice treating systemic lupus erythematosus—A single-centre retrospective longitudinal study in Japan},
  journal = {Modern Rheumatology},
  year = {2026},
  doi = {10.1093/mr/roag001}
}
Kostenlos starten →